The eligibility for local‐regional treatment of peritoneal surface malignancy

VJ Verwaal, S Kusamura, D Baratti… - Journal of Surgical …, 2008 - Wiley Online Library
Abstract At the Fifth International Workshop on Peritoneal Surface Malignancy, held in Milan,
the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface …

Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancer

AAK Tentes, S Kakolyris, D Kyziridis… - Journal of …, 2012 - Wiley Online Library
Background/Aims. Intraperitoneal intraoperative hyperthermic chemotherapy (HIPEC) has
been used in the treatment of ovarian cancer. The purpose of the study is to determine the …

Long-term survival in patients with epithelial ovarian cancer following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)

O Le Saux, E Decullier, G Freyer… - International Journal of …, 2018 - Taylor & Francis
Objective: Despite a high response rate to first-line therapy, prognosis of epithelial ovarian
carcinoma (EOC) remains poor. The objective of the present study was to evaluate the …

Prognostic Value of En-Block Radical Bowel Resection in Advanced Ovarian Cancer Surgery With HIPEC

T Panoskaltsis, C Papadimitriou, N Pallas… - Cancer …, 2023 - journals.sagepub.com
Purpose To identify prognostic factors of survival and recurrence in advanced ovarian
cancer patients undergoing radical surgery and HIPEC. Methods In a single Department of …

[PDF][PDF] Ovarian cancer: 20-year experience with cytoreductive surgery and perioperative intraperitoneal chemotherapy

K Ntatsis, E Papantoni, D Kyziridis, A Kalakonas… - J BUON, 2021 - jbuon.com
Purpose: Complete cytoreduction has been established as the most significant factor of long-
term survival in epithelial ovarian cancer. Perioperative intraperitoneal chemotherapy has …

[图书][B] Surgery for ovarian cancer: principles and practice

RE Bristow, BY Karlan, DS Chi - 2010 - taylorfrancis.com
This comprehensive surgical text has been updated and expanded and includes the
important techniques essential to the effective management of ovarian cancer, with …

Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer: 18 years of experience

A Liberis, D Kyziridis, A Kalakonas… - European Journal of …, 2024 - Elsevier
Aim To identify the clinical and pathological factors associated with relapse in women who
had undergone secondary cytoreductive surgery due to locally advanced recurrent ovarian …

Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer

AAK Tentes, OS Korakianitis, S Kakolyris… - Tumori …, 2010 - journals.sagepub.com
Background and aims Cytoreductive surgery with perioperative intraperitoneal
chemotherapy is another approach for recurrent ovarian cancer. The purpose of the study …

Современные реалии и возможности хирургического лечения рака яичников

ИР Рахматуллина, ГВ Хамитова… - Медицинский вестник …, 2013 - cyberleninka.ru
Рак яичников в структуре злокачественных новообразований женских половых органов
характеризуется неоднозначным прогнозом и самым высоким показателем …

[引用][C] Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer

L Ansaloni, V Agnoletti, A Amadori… - International …, 2012 - BMJ Specialist Journals